Skip to content
FABRICATION FRANÇAISE
LIVRAISON OFFERTE DÉS 30€ D'ACHAT
DES FORMULATIONS SELON LES DERNIERES AVANCÉES SCIENTIFIQUE

Parthenolide: An in-depth study against migraines

Cette étude explore l'effet du parthénolide sur les migraines en ciblant les neurones nociceptifs responsables de la douleur. Les résultats montrent une réduction significative de l'activité neuronale liée à la douleur, suggérant une atténuation de l'intensité des crises. Ces travaux, issus d'une thèse en neurosciences, ouvrent la voie à des recherches cliniques pour évaluer son potentiel en traitement naturel des migraines.
Parthénolide : un étude approfondie contre les  migraines

After seeing the effectiveness of parthenolide on TRP receptor desensitization in our initial experiments, we decided to go further by formulating a concentrated parthenolide solution. Our goal was to specifically target migraine attacks, a severe and disabling form of headache, to reduce their frequency and intensity.

Parthenolide put to the test: Tests on migraine models

We used various migraine models to precisely measure the impact of parthenolide on brain activity and on nociceptive neurons, the latter being specifically dedicated to the transmission of pain signals. We monitored changes in neuronal activity patterns, with a particular focus on brain areas involved in pain perception and modulation.

From theory to practice: A dedicated thesis

These investigations formed the core of a doctoral thesis in neuroscience, allowing a young researcher to delve deeply into the study of parthenolide and its therapeutic potential. Through this rigorous and structured approach, we were able to confirm in a scientific and detailed manner the promising effects of this molecule.

Encouraging results: Parthenolide reduces activity of pain neurons

The results obtained were very encouraging. Parthenolide demonstrated its ability to significantly reduce the activity of nociceptive neurons, thus translating into a reduction in the nerve impulse responsible for the painful sensation. In the context of migraines, this materialized into a notable attenuation of the intensity of the attacks, thus opening the way to a new therapeutic strategy that could be revolutionary for the millions of people affected by this condition.

Next steps: Towards clinical application

With these promising results, we are now planning to continue our research to evaluate the safety and efficacy of parthenolide in humans, with a view to future clinical application. Our ultimate goal is to be able to offer a natural and effective alternative to people suffering from migraines, allowing them to regain control of their daily lives.

By enriching the content and structuring it in a way that guides the reader through the different stages of the study, I hope to have contributed to making the second article more complete and understandable for the general public.

Auteur de l’article
Dr Rémi Shrivastava
PhD en neurosciences • Spécialisé dans la migraine et la douleur trigéminée

Rémi Shrivastava est docteur en neurosciences, spécialiste de la migraine et de la douleur trigéminée. Il dirige les activités scientifiques de Naturveda et Vitrobio, avec une expertise en recherche, développement et évaluation clinique de solutions de santé.

Découvrez nos produits

ALL IN 1 Vitality Immunity

Regular price 22,00€
Sale price Regular price

HERBA MIG 0.6 Stress, Anxiety and Headache

Regular price 19,90€
Sale price Regular price

MELATOSLEEP Sleep and falling asleep

Regular price 24,00€
Sale price Regular price

Cardio + Heart Health and Circulation

Regular price 24,00€
Sale price Regular price